About
Tesamorelin
Tesamorelin is a growth hormone releasing hormone analog originally developed for reduction of visceral adipose tissue in specific medical populations.
Potential Benefits
-May support visceral fat reduction
-May support body composition
-May support metabolic health
-May support recovery and healthy aging pathways
How It Works
Tesamorelin stimulates the pituitary to increase growth hormone release, which can influence IGF-1 signaling, lipolysis, and body composition.
Safety Considerations
Baseline labs are required before starting and follow-up labs are required periodically.
Growth hormone secretagogues may stimulate cell proliferation and could accelerate growth of pre-existing cancer or neoplastic conditions.
Possible side effects include water retention, joint pain, glucose changes, numbness or tingling, and injection site reactions.
Not recommended during pregnancy or breastfeeding.
Quick Facts
Category
Metabolic Health & Weight Management
Available Strengths
10 mg; 20 mg
Evidence Level
FDA-approved drug for HIV-associated lipodystrophy; off-label wellness use requires caution
Lab Monitoring
Required
The information on this page is provided for educational purposes only and is not medical advice. Peptide therapies may not be appropriate for all individuals. Treatment recommendations are made only after consultation with a qualified healthcare provider.